Use mechanical milling to produce drug particles in the micrometer range.

Nanonization: Employ high-pressure homogenization or wet media milling to create nanoparticles for enhanced dissolution rates.

Spray Drying: Convert the API into fine particles using spray drying techniques to improve solubility.

Smaller particle sizes significantly enhance dissolution and absorption.

Step 2: Use Solubility-Enhancing Excipients

Incorporating excipients that enhance solubility can improve drug dissolution. Recommendations include:

• Surfactants: Add surfactants like sodium lauryl sulfate (SLS) to reduce surface tension and increase wetting.
• Cyclodextrins: Form inclusion complexes with cyclodextrins to improve solubility and stability.
• Co-Solvents: Use co-solvents like ethanol or propylene glycol to dissolve the drug in the formulation.

Solubility-enhancing excipients facilitate better drug release in the GI tract.

Step 3: Develop Solid Dispersions

Solid dispersions involve dispersing the API in a hydrophilic carrier matrix to improve solubility and dissolution. Methods include:

• Hot-Melt Extrusion: Melt the drug with a polymer carrier (e.g., polyethylene glycol or HPMC) to create a uniform dispersion.
• Solvent Evaporation: Dissolve the API and polymer in a solvent, then evaporate the solvent to form a solid dispersion.
• Spray Drying: Produce fine, amorphous particles with improved dissolution characteristics.

Solid dispersions transform poorly soluble APIs into amorphous forms with enhanced solubility.

Step 4: Modify the Tablet Formulation

Formulation adjustments can significantly improve bioavailability. Key strategies include:

• Disintegrants: Add superdisintegrants like croscarmellose sodium or sodium starch glycolate to promote rapid tablet disintegration.
• Lipid-Based Systems: Incorporate lipids like medium-chain triglycerides (MCTs) to enhance solubility and absorption.
• Matrix Formers: Use polymers such as HPMC or PVP to control drug release and maintain solubility.

Proper formulation design ensures optimal drug release and absorption.

Step 5: Explore Advanced Drug Delivery Systems

Innovative delivery systems improve bioavailability by enhancing solubility and absorption. Options include:

• Self-Emulsifying Drug Delivery Systems (SEDDS): Formulate the drug in a lipid-based system that emulsifies upon contact with GI fluids.
• Nanoparticle Formulations: Use polymeric or lipid-based nanoparticles to improve dissolution and target drug delivery.
• Osmotic Pumps: Employ osmotic systems to release poorly soluble drugs in a controlled manner.

Advanced systems address both solubility and permeability challenges.

Step 6: Conduct In-Vitro and In-Vivo Testing

Rigorous testing validates the effectiveness of bioavailability-enhancing strategies. Essential tests include:

• Dissolution Testing: Evaluate drug release profiles under simulated gastrointestinal conditions.
• Permeability Testing: Use Caco-2 cell models or other systems to assess drug absorption potential.
• Pharmacokinetic Studies: Conduct in-vivo studies to measure drug bioavailability and absorption.

Testing ensures the formulation meets therapeutic and regulatory requirements.

Step 7: Optimize Manufacturing Processes

Consistent manufacturing processes are essential for achieving reproducible bioavailability. Focus on:

• Granulation Techniques: Use wet or dry granulation to create uniform granules that enhance dissolution.
• Compression Force: Avoid excessive compression to prevent reduced tablet porosity and dissolution.
• Coating Application: Apply coatings that do not hinder drug dissolution or absorption.

Optimized processes ensure consistent quality across batches.

Step 8: Address Stability Challenges

Maintaining stability is crucial for ensuring long-term bioavailability. Recommendations include:

• Moisture Protection: Use moisture-resistant packaging to prevent hydrolysis or degradation.
• Thermal Stability: Store tablets under controlled temperatures to maintain drug integrity.
• Antioxidants: Incorporate stabilizers to protect the drug from oxidative degradation.

Stability measures preserve the formulation’s bioavailability over time.

Conclusion

Enhancing bioavailability in tablets for poorly soluble drugs requires a multifaceted approach that combines particle size reduction, solubility-enhancing excipients, advanced delivery systems, and rigorous testing. By addressing solubility and permeability barriers, optimizing formulations, and refining manufacturing processes, manufacturers can ensure effective drug delivery and improved patient outcomes. These strategies meet regulatory standards while providing high-quality, therapeutic products.